The modern features of optimal therapy of salpingoforite

О. В. Булавенко, Д. Г. Коньков, О. М. Гончаренко

Abstract


The aim of the prospective study was to investigate the clinical efficacy of Tamistol and Bifiten in the complex treatment of salpingoophoritis.

Patients and methods. The study involved 152 patients of reproductive age with salpingoophoritis. All women were divided into 3 groups: I – 48 patients received traditional therapy; II – 54 patients who received complex anti-inflammatory treatment with vaginal application of a combined drug containing neomycin sulfate 35,000 IU, polymyxin B sulfate 35,000 IU and nystatin 100,000 IU; III – 50 women, each of whom in addition to traditional therapy received Tamistol and the synbiotic Bifiten. The comparative assessment of the effectiveness of treatment was conducted on the basis of regression of women’s complaints and the results of bacteriological research in dynamics.

Results. The local application of suppositories Tamistol or combined drug with neomycin sulfate, polymyxin B sulfate and nystatin had a pronounced clinical effect in the treatment of salpingooophoritis. However, the use of suppositories of Tamistol and Bifiten capsules were more effective than the use of combined drug to reduce the incidence of dysbiosis (RR 2.01, 95% CI 1.14–3.53, p = 0.02 and RR 4.63, 95% CI 1.43–15.04, p = 0.01), for a higher number of lactobacilli (RR 1.99, 95% CI 1.17–3.40, p = 0.011 and RR 5.45 95% CI 1,71–17,41, p = 0,004) on the 14th and 30th day of the study.

Conclusion. Use of suppositories Tamistol and capsules Bifiten was clinically highly effective in the complex therapy of salpingoophoritis. The combination of suppositories Tamistol and Bifiten capsules per os requires further investigation.


Keywords


salpingoophoritis; dysbiosis; miramistin; Tamistol; synbiotics; Bifiten

References


Antonenko, I.V. “Сurrent pathogenetic aspects of the treatment of inflammatory diseases of internal female reproductive organs.” Reproductive Endocrinology 4.30 (2016): 70–4.

Gorpynchenko, I.I., Gurzhenko, I.M. “The usage of medicine Miramistin during complex treatment of patients with chronic urethritis and urethroprostatitis.” Men’s Health 3 (2013): 78–81.

Kosei, N.V. “Modern principles of pelvic inflammatory diseases treatment.” In: Reproductive Endocrinology. Almanac of reproductive health. Kyiv (2013): 182–92.

Markin, L.B., Shakhova O.V. “New approaches to antimicrobial and anti-inflammatory therapy of urogenital infections.” Clinical Pharmacy, Pharmacotherapy and Medical Standardization 3–4 (2015): 110–3.

Pyrohova, V.I., Shurpyak, S.A. “The prospect of using synbiotics Bifiten in clinical practice obstetricians and gynecologists.” Women’s Health 10.106 (2015): 65–8.

Tsmur, O.V., Levchuk, O.B., Liashyna, K.V., Boyko, N.V. “Results of using the domestic synbiotic Bifiten for treatment of bacterial vaginosis of pregnant women.” Women’s Health 6.12 (2016): 70–5.

Falagas, M.E., Betsi, G.I., Athanasiou, S. “Probiotics for the treatment of women with bacterial vaginosis.” Clin Microbiol Infect 13 (2007): 657–64.

Shenderov, B.A. “Probiotics, prebiotics and synbiotics. General and selected fields of problem.” Food ingredients. Raw materials and additives 2 (2005): 23–6.


GOST Style Citations


1. Антоненко, И.В. Патогенетические аспекты лечения воспалительных заболеваний внутренних женских половых органов на современном этапе / И.В. Антоненко // Репродуктивная эндокринология. – 2016. – №4 (30). – С. 70–74.

2. Горпинченко, І.І. Порівняльне вивчення клінічної ефективності препарату Мірамистин у порівнянні з препаратами Бетадин та Хлоргексидин біглюконат у комплексному лікуванні хворих на хронічний уретрит і уретропростатит // І.І. Горпинченко, Ю.М. Гурженко // Здоровье мужчины. – 2012. – №3. – С.78–81.

3. Косей, Н.В. Современные принципы лечения воспалительных заболеваний женских половых органов / Н.В. Косей // Репродуктивная эндокринология. Альманах репродуктивного здоровья. – Киев, 2013. – С. 182–192.

4. Маркін, Л.Б. Cучасні підходи до антимікробної та протизапальної терапії урогенітальної інфекції / Л.Б. Маркін, О.В. Шахова // Клінічна фармація, фармакотерапія та медична стандартизація. – 2015. – №3–4. – С.110–113.

5. Пирогова, В.І. Перспективи використання синбіотика Біфітен у клінічній практиці акушера-гінеколога / В.І. Пирогова, С.О. Шурпяк // Здоровье женщины. – 2015. – №10 (106). – С.65–68.

6. Цмур, О.В. Результаты применения отечественного синбиотика Бифитен для терапии бактериальных вагинозов у беременных /О.В. Цмур, О.Б. Левчук, К.В. Ляшина, Н.В. Бойко // Здоровье женщины. – 2016. – №6 (112). – С.70–75.

7. Falagas, M.E., Betsi, G.I., Athanasiou, S. “Probiotics for the treatment of women with bacterial vaginosis.” Clin Microbiol Infect 13 (2007): 657–64.

8. Shenderov, B.A. “Probiotics, prebiotics and synbiotics. General and selected fields of problem.” Food ingredients. Raw materials and additives 2 (2005): 23–6.





DOI: https://doi.org/10.18370/2309-4117.2017.36.58-62

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)